It was well known that Wnt/MAPK/PI3K-AKT signaling pathway promoted the progression of EMT in lung cancer, prostate cancer, nasopharyngeal carcinoma, cervical cancer, breast cancer, and so on50–54. The gene discussed is AKT1; the disease is lung cancer.